Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (-/-) mice

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 2, 2009, Pages 211-218

  Nakken, Karl E ^a   Nygard, Stale ^a   Haaland, Terese K ^a   Berge, Knut E ^b   Ødegaard, Annlaug ^a   Labori, Knut J ^a   Ræder, Morten G ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Abcb4; Cholic acid; Chronic cholangitis; mdr2; Stellate cells; Ursodeoxycholic acid

Indexed keywords

CHOLIC ACID; COMPLEMENTARY DNA; URSODEOXYCHOLIC ACID;

ABCB4 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL2 GENE; CCL20 GENE; COL1A1 GENE; COL1A2 GENE; COL4A1 GENE; CONTROLLED STUDY; CTGF GENE; CXCL10 GENE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DNA MICROARRAY; ELF3 GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HEPATITIS; HISTOPATHOLOGY; HYPOTHESIS; LGALS3 GENE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER REGENERATION; MOUSE; NFKB1 GENE; NFKB2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PDGFA GENE; PDGFRB GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCLEROSING CHOLANGITIS; SPARC GENE; SPP1 GENE; TGFBETA1 GENE; UPREGULATION;

EID: 61649107471     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802400867     Document Type: Article

References (26)

1. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-51.
2. Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 2005;43:1045-54.
3. Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2006;130:465-81.
4. Henkel C, Roderfeld M, Weiskirchen R, Berres ML, Hillebrandt S, Lammert F, et al. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 2006;6:6538-48.
5. Baghdasaryan A, Fickert P, Fuchsbichler A, Silbert D, Gumhold J, Horl G, et al. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int 2008;28:948-58.
6. Mauad TH, Van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994;145:1237-45.
7. Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004;127:261-74.
8. Hui AY, Friedman SL. Molecular basis of hepatic fibrosis. Expert Rev Molecular Med 2003;5:1-23.
9. Nakken KE, Nygard S, Haaland T, Berge KE, Arnkvaern K, Odegaard A, et al. Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/-) mice harbouring chronic cholangitis. Scand J Gastroenterol 2007;42:1245-55.
10. Van Nieuwkerk CM, Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996;111:165-71.
11. van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Archiv-A (Pathol Anat Histopathol) 1987;412:63-72.
12. Snedecor GW, Cochran WG. Statistical methods, 6th ed. Iowa, USA: Iowa State University Press; 1971.
13. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
14. Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 1998;275:269-78.
15. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-50.
16. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989;84:1786-93.
17. Melton AC, Soon RK Jr, Park JG, Martinez L, Dehart GW, Yee HF Jr. Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis. Am J Physiol 2007;293:G1272-80.
18. Knittel T, Schuppan D, Meyer zum Buschenfelde KH, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology 1992;102:1724-35.
19. Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, et al. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 2004;40:1106-15.
20. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72.
21. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997;214:27-40.
22. Prud'homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007;87:1077-91.
23. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annua Rev Immunol 1998;16:137-61.
24. Friedrichsen S, Heuer H, Christ S, Cuthill D, Bauer K, Raivich G. Gene expression of connective tissue growth factor in adult mouse. Growth Factors 2005;23:43-53.
25. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-9.
26. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996;7:469-80.